UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934*
(Amendment No. 2)
| MEI Pharma, Inc. |
|
(Name of Issuer)
Common Stock, $0.01 par value |
|
(Title of Class of Securities)
55279B202 |
|
(CUSIP Number)
May 31, 2022 |
| (Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
| ☒ | Rule 13d-1(b) | |
| ☐ | Rule 13d-1(c) | |
| ☐ | Rule 13d-1(d) |
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No . | 55279B202 | Page 2 of 7 |
| 1 |
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS 46-3521994 |
|||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ☐ (b) ☐ | ||
| 3 | SEC USE ONLY | |||
| 4 |
CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
|||
|
NUMBER OF BENEFICIALLY EACH PERSON |
5 |
SOLE VOTING POWER 0 |
||
| 6 |
SHARED VOTING POWER 0 |
|||
| 7 |
SOLE DISPOSITIVE POWER 0 |
|||
| 8 |
SHARED DISPOSITIVE POWER 0 |
|||
| 9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 |
|||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES | ☐ | ||
| 11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0.0% |
|||
| 12 |
TYPE OF REPORTING PERSON IA |
|||
| CUSIP No . | 55279B202 | Page 3 of 7 |
| 1 |
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS |
|||||||||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ☐ (b) ☐ | ||||||||||
| 3 | SEC USE ONLY | |||||||||||
| 4 |
CITIZENSHIP OR PLACE OF ORGANIZATION United State of America |
|||||||||||
|
NUMBER OF BENEFICIALLY EACH PERSON |
5 |
SOLE VOTING POWER 10,000 |
||||||||||
| 6 |
SHARED VOTING POWER 6,000 |
|||||||||||
| 7 |
SOLE DISPOSITIVE POWER 10,000 |
|||||||||||
| 8 |
SHARED DISPOSITIVE POWER 6,000 |
|||||||||||
| 9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 16,000 |
|||||||||||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES | ☐ | ||||||||||
| 11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0.01% |
|||||||||||
| 12 |
TYPE OF REPORTING PERSON IN |
|||||||||||
| CUSIP No. | 55279B202 | Page 4 of 7 |
| Item 1(a). | Name of Issuer: | ||
| MEI Pharma, Inc. | |||
| Item 1(b). | Address of Issuer’s Principal Executive Offices: | ||
| 11455 El Camino Real, Suite 250, San Diego, CA 92130 | |||
| Item 2(a). | Name of Person Filing: | ||
|
This Schedule 13G is being jointly filed by the following:
First Light Asset Management, LLC (the “Manager”) Mathew P. Arens (“Mr. Arens”) | |||
|
The Manager may be deemed to be the beneficial owner of 0 of the Issuer’s shares of common stock (the “Shares”). Mr. Arens also directly holds 10,000 Shares in an individual capacity with sole control and 6,000 Shares held in a joint spousal account over which he shares control. The Manager and Mr. Arens are filing this Schedule 13G/A with respect to these Shares pursuant to Rule 13d-1(b) under the Act.
The Manager and Mr. Arens may be deemed to be the beneficial owner of the total amount of Shares set forth across from its or his respective name in Item 4 below. The filing of this Schedule 13G shall not be construed as an admission that the reporting persons or any of their affiliates are the beneficial owner of any securities covered by this Schedule 13G for any other purposes other than Section 13(d) of the Securities Exchange Act of 1934. | |||
| Item 2(b). | Address of Principal Business Office or, if None, Residence: | ||
|
Each of the reporting persons identified in Item 2(a) has its principal business office at:
3300 Edinborough Way, Suite 201, Edina, MN 55435 | |||
| Item 2(c). | Citizenship: | ||
|
First Light Asset Management, LLC – Delaware limited liability company Mathew P. Arens – United States citizen | |||
| Item 2(d). | Title of Class of Securities: | ||
| Common Stock, $0.01 par value | |||
| Item 2(e). | CUSIP Number: | ||
| Item 3. | If This Statement is Filed Pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), Check Whether the Person Filing is a: | ||
| (a) | ☐ | Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). | |
| (b) | ☐ | Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). | |
| (c) | ☐ | Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). | |
| (d) | ☐ | Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). | |
| (e) | ☒ | An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); | |
| CUSIP No . | 55279B202 | Page 5 of 7 | ||||
| (f) | ☐ | An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); | ||||
| (g) | ☒ | A parent holding company or control person in accordance with §240.13d-1(b)(ii)(G); | ||||
| (h) | ☐ | A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); | ||||
| (i) | ☐ | A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3); | ||||
| (j) | ☐ | Group, in accordance with §240.13d-1(b)(1)(ii)(J). | ||||
| Item 4. | Ownership. | |||||
| Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. | ||||||
| (a) | Amount beneficially owned: | |||||
|
First Light Asset Management, LLC – 0 Mathew P. Arens – 16,000 | ||||||
| (b) | Percent of class: | |||||
|
First Light Asset Management, LLC – 0.00% Mathew P. Arens – 0.01% | ||||||
| (c) | Number of shares as to which such person has: | |||||
| (i) | Sole power to vote or to direct the vote | |||||
|
First Light Asset Management, LLC – 0 Mathew P. Arens – 10,000 | ||||||
| (ii) | Shared power to vote or to direct the vote | |||||
|
First Light Asset Management, LLC – 0 Mathew P. Arens – 6,000 | ||||||
| (iii) | Sole power to dispose or to direct the disposition of | |||||
|
First Light Asset Management, LLC – 0 Mathew P. Arens – 10,000 | ||||||
| (iv) | Shared power to dispose or to direct the disposition of | |||||
|
First Light Asset Management, LLC – 0 Mathew P. Arens – 6,000 | ||||||
| CUSIP No . | 55279B202 | Page 6 of 7 |
| Item 5. | Ownership of Five Percent or Less of a Class. |
| If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒ | |
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
| Not applicable | |
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
| Not applicable | |
| Item 8. | Identification and Classification of Members of the Group. |
| Not applicable | |
| Item 9. | Notice of Dissolution of Group. |
| Not applicable | |
| Item 10. | Certification. |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
FIRST LIGHT ASSET MANAGEMENT, LLC
Date: May 31, 2022 |
||
| By: | /s/ Kurt T. Peterson | |
| Name: | Kurt T. Peterson | |
| Title: | Chief Compliance Officer | |
|
Date: May 31, 2022 |
||
| Signature: | /s/ Mathew P. Arens | |
| Name: | Mathew P. Arens | |
| CUSIP No . | 55279B202 | Page 7 of 7 |
Exhibit A
JOINT FILING AGREEMENT
The Undersigned agree that the statement on Schedule 13G with respect to the common stock of MEI Pharma, Inc, dated as of May 31, 2022, is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each of them pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
FIRST LIGHT ASSET MANAGEMENT, LLC
| By: | /s/ Kurt T. Peterson | |
| Name: | Kurt T. Peterson | |
| Title: | Chief Compliance Officer |
| Signature: | /s/ Mathew P. Arens | |
| Name: | Mathew P. Arens |